Top 10 Medical AI Stocks on Wall Street’s Radar

5. Recursion Pharmaceuticals (NASDAQ:RXRX)

Number of Hedge Fund Holders: 16

Recursion Pharmaceuticals (NASDAQ:RXRX) is an emerging clinical-stage biotech firm that uses AI, bioinformatics, experimental biology, and automation to industrialize drug discovery for various diseases. It also collaborates with leaders in the drug discovery space to reduce timelines and costs for identifying and optimizing lead candidates.

On January 17th, J.P. Morgan said that Recursion Pharmaceuticals’ (NASDAQ:RXRX) presentation updates at the firm’s recently held healthcare conference were “largely in line/as anticipated.” Analysts believe it will take definitive clinical wins from the company’s pipeline to validate the evolving platform and “for shares to become constructive by extension.” The brokerage maintained a “Neutral” rating on the stock.